Difference between revisions of "Nilutamide (Nilandron)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "manufacturer. Instead" to "manufacturer. Instead") |
m |
||
| Line 1: | Line 1: | ||
| − | |||
| − | |||
==General information== | ==General information== | ||
Class/mechanism: Antiandrogen, nonsteroidal. Nilutamide competitively inhibits the effects of testosterone by interacting with the androgen receptor.<ref name="insert">[http://products.sanofi.us/nilandron/nilandron.pdf Nilutamide (Nilandron) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/nilutamide.pdf Nilutamide (Nilandron) package insert (locally hosted backup)]</ref> | Class/mechanism: Antiandrogen, nonsteroidal. Nilutamide competitively inhibits the effects of testosterone by interacting with the androgen receptor.<ref name="insert">[http://products.sanofi.us/nilandron/nilandron.pdf Nilutamide (Nilandron) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/nilutamide.pdf Nilutamide (Nilandron) package insert (locally hosted backup)]</ref> | ||
| Line 14: | Line 12: | ||
*[http://chemocare.com/bio/nilutamide.asp Nilutamide (Nilandron) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/nilutamide.asp Nilutamide (Nilandron) patient drug information (Chemocare)]</ref> | *[http://chemocare.com/bio/nilutamide.asp Nilutamide (Nilandron) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/nilutamide.asp Nilutamide (Nilandron) patient drug information (Chemocare)]</ref> | ||
*[http://www.uptodate.com/contents/nilutamide-patient-drug-information Nilutamide (Nilandron) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/nilutamide-patient-drug-information Nilutamide (Nilandron) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/nilutamide-patient-drug-information Nilutamide (Nilandron) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/nilutamide-patient-drug-information Nilutamide (Nilandron) patient drug information (UpToDate)]</ref> | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Brand names:''' Anandron, Nilandron, Zandron | ||
==References== | ==References== | ||
| Line 19: | Line 20: | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
| + | [[Category:Oral medications]] | ||
| + | |||
[[Category:Endocrine therapy]] | [[Category:Endocrine therapy]] | ||
[[Category:Antiandrogens]] | [[Category:Antiandrogens]] | ||
| + | [[Category:Nonsteroidal androgen receptor inhibitors]] | ||
| + | |||
[[Category:Prostate cancer medications]] | [[Category:Prostate cancer medications]] | ||
[[Category:Drugs FDA approved in 1996]] | [[Category:Drugs FDA approved in 1996]] | ||
Revision as of 16:09, 29 March 2018
General information
Class/mechanism: Antiandrogen, nonsteroidal. Nilutamide competitively inhibits the effects of testosterone by interacting with the androgen receptor.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
Patient drug information
- Nilutamide (Nilandron) patient drug information (Chemocare)[3]
- Nilutamide (Nilandron) patient drug information (UpToDate)[4]
Also known as
- Brand names: Anandron, Nilandron, Zandron